163 related articles for article (PubMed ID: 36929633)
21. Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling.
Holtz AM; VanCoillie R; Vansickle EA; Carere DA; Withrow K; Torti E; Juusola J; Millan F; Person R; Guillen Sacoto MJ; Si Y; Wentzensen IM; Pugh J; Vasileiou G; Rieger M; Reis A; Argilli E; Sherr EH; Aldinger KA; Dobyns WB; Brunet T; Hoefele J; Wagner M; Haber B; Kotzaeridou U; Keren B; Heron D; Mignot C; Heide S; Courtin T; Buratti J; Murugasen S; Donald KA; O'Heir E; Moody S; Kim KH; Burton BK; Yoon G; Campo MD; Masser-Frye D; Kozenko M; Parkinson C; Sell SL; Gordon PL; Prokop JW; Karaa A; Bupp C; Raby BA
Genet Med; 2022 Oct; 24(10):2065-2078. PubMed ID: 35980381
[TBL] [Abstract][Full Text] [Related]
22. Multiple myosin motors interact with sodium/potassium-ATPase alpha 1 subunits.
Dash B; Dib-Hajj SD; Waxman SG
Mol Brain; 2018 Aug; 11(1):45. PubMed ID: 30086768
[TBL] [Abstract][Full Text] [Related]
23. Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia.
Fang X; Bai Y; Zhang L; Ding S
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496549
[TBL] [Abstract][Full Text] [Related]
24. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
25. Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons.
Recuenco MC; Ohmori T; Tanigawa S; Taguchi A; Fujimura S; Conti MA; Wei Q; Kiyonari H; Abe T; Adelstein RS; Nishinakamura R
J Am Soc Nephrol; 2015 May; 26(5):1081-91. PubMed ID: 25168025
[TBL] [Abstract][Full Text] [Related]
26. MYH9 promotes cell metastasis
Yang B; Liu H; Bi Y; Cheng C; Li G; Kong P; Zhang L; Shi R; Zhang Y; Zhang R; Cheng X
Int J Med Sci; 2020; 17(13):2013-2023. PubMed ID: 32788880
[TBL] [Abstract][Full Text] [Related]
27. A Mec17-Myosin II Effector Axis Coordinates Microtubule Acetylation and Actin Dynamics to Control Primary Cilium Biogenesis.
Rao Y; Hao R; Wang B; Yao TP
PLoS One; 2014; 9(12):e114087. PubMed ID: 25494100
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer.
Qiu JJ; Lin YY; Ding JX; Feng WW; Jin HY; Hua KQ
Int J Oncol; 2015; 46(6):2497-505. PubMed ID: 25845387
[TBL] [Abstract][Full Text] [Related]
29. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy.
Johnstone DB; Zhang J; George B; Léon C; Gachet C; Wong H; Parekh R; Holzman LB
Mol Cell Biol; 2011 May; 31(10):2162-70. PubMed ID: 21402784
[TBL] [Abstract][Full Text] [Related]
30. MYH9: A key protein involved in tumor progression and virus-related diseases.
Liu Q; Cheng C; Huang J; Yan W; Wen Y; Liu Z; Zhou B; Guo S; Fang W
Biomed Pharmacother; 2024 Feb; 171():116118. PubMed ID: 38181716
[TBL] [Abstract][Full Text] [Related]
31. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
32. MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment.
Singh SK; Sinha S; Padhan J; Jangde N; Ray R; Rai V
Med Oncol; 2020 Sep; 37(10):88. PubMed ID: 32902730
[TBL] [Abstract][Full Text] [Related]
33. HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas.
Que T; Zheng H; Zeng Y; Liu X; Qi G; La Q; Liang T; Li Z; Yi G; Zhang S; Li J; Nie J; Tan JE; Huang G
Cell Death Dis; 2021 Dec; 12(12):1147. PubMed ID: 34887392
[TBL] [Abstract][Full Text] [Related]
34. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.
Wu AY; Gu LY; Cang W; Cheng MX; Wang WJ; Di W; Huang L; Qiu LH
J Exp Clin Cancer Res; 2019 Apr; 38(1):176. PubMed ID: 31023317
[TBL] [Abstract][Full Text] [Related]
35. CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis.
Yu ST; Sun BH; Ge JN; Shi JL; Zhu MS; Wei ZG; Li TT; Zhang ZC; Chen WS; Lei ST
Front Endocrinol (Lausanne); 2020; 11():535. PubMed ID: 32982961
[TBL] [Abstract][Full Text] [Related]
36. Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.
Soyama H; Miyamoto M; Takano M; Aoyama T; Matsuura H; Sakamoto T; Takasaki K; Kuwahara M; Kato K; Yoshikawa T; Iwahashi H; Tsuda H; Furuya K
Med Oncol; 2017 Nov; 34(12):201. PubMed ID: 29168038
[TBL] [Abstract][Full Text] [Related]
37. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
38. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.
Hu S; Ren S; Cai Y; Liu J; Han Y; Zhao Y; Yang J; Zhou X; Wang X
Cell Death Differ; 2022 Mar; 29(3):642-656. PubMed ID: 34743203
[TBL] [Abstract][Full Text] [Related]
39. Mosaic loss of non-muscle myosin IIA and IIB is sufficient to induce mammary epithelial proliferation.
Nguyen-Ngoc KV; Silvestri VL; Georgess D; Fairchild AN; Ewald AJ
J Cell Sci; 2017 Oct; 130(19):3213-3221. PubMed ID: 28821574
[TBL] [Abstract][Full Text] [Related]
40. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.
Haslehurst AM; Koti M; Dharsee M; Nuin P; Evans K; Geraci J; Childs T; Chen J; Li J; Weberpals J; Davey S; Squire J; Park PC; Feilotter H
BMC Cancer; 2012 Mar; 12():91. PubMed ID: 22429801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
